3-Substituted oxindole &bgr; 3 agonists
US6825220B2 · kind B2 · utility
8Cited by
5References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 11, 2003 |
| Grant date | Nov 30, 2004 |
| Priority date | — |
| Expiry date | Apr 11, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a &bgr;;3 adrenergic receptor agonist of formula I: (1); or a pharmaceutical salt thereof; which is useful for treating Type II diabetes and/or obesity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.